A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia.

Authors	Alessandro Broccoli, Lisa Argnani, Matthew Cross, Agnieszka Janus, Elsa Maitre, Xavier Troussard, Tadeusz Robak, Claire Dearden, Monica Else, Daniel Catovsky, Pier Luigi Zinzani
Journal	Blood advances (Blood Adv) Vol. 6 Issue 14 Pg. 4224-4227 (07 26 2022) ISSN: 2473-9537 [Electronic] United States
PMID	35584397 (Publication Type: Journal Article, Multicenter Study)
Chemical References	Antineoplastic Agents Cladribine
Topics	Antineoplastic Agents (adverse effects) Cladribine (therapeutic use) Humans Leukemia, Hairy Cell (drug therapy) Remission Induction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!